Skip to main content

Table 1 Interpretation time, results and sensitivity/specificity for each modality against the reported comparator

From: Novel three-dimensional bone ‘mapping’ software can help assess progression of osseous metastases from routine CT

Test modality Mean interpretation time (s) Malignant areas Suspicious areas Compar-ator Sensitivity
(Exc ‘sus’)
Specificity
(Exc ‘sus’)
Sensitivity
(Inc ‘sus’)
Specificity
(Inc ‘sus’)
Bone Map 96.3 235 47 CT 70.71 73.08 69.05 58.28
CT 222.1 264 28 BS 85.63 64.71 81.56 62.89
  1. These were assessed including or excluding calls of suspicious (‘sus’) areas